Biography
Graduate of Saarland University (2011). Training in internal medicine, medical haematology and oncology at Saarland University Hospital (UKS).
Teaching and research activities at Saarland University Hospital since 2012, doctorate with magna cum laude in 2013, habilitation and award of venia legendi in internal medicine in 2023.
Author and co-author of over 50 original scientific papers.
Internist since 2017, haematologist and oncologist since 2020. Dr Kaddu-Mulindwa was medical director of the internal emergency department of Saarland University Hospital from 2017-2019 and has been a senior physician in the Department of Oncology, Haematology, Clinical Immunology and Rheumatology (Internal Medicine I) at the UKS since 2017.
He has also headed the HIV outpatient clinic of the Clinic for Internal Medicine I since 2017 and, as centre coordinator, ensured the clinic's certification as a centre for haematological neoplasms.
He holds additional qualifications in emergency medicine, clinical acute and emergency medicine and palliative medicine and is an antibiotic stewardship expert.
He is a member of various national and international professional societies and worked for many years as an investigator for clinical trials. As part of this, he has headed the clinical study office of the Clinic for Internal Medicine I (UKS) since 2020.
He has the further training authorisation of the Saarland Medical Association in the subject of internal medicine (18 months) and haematology / oncology (12 months).
Since July 2020, he has been the managing senior physician at the Clinic for Internal Medicine I (UKS) and has been working as an oncologist and haematologist at the CHdN /Clinique St Louis in Ettelbruck with his colleagues Dr Claude Schalbar and Dr Frank Jacob since October 2021.
He successfully passed the ESMO (European Society of Oncology) examination for oncologists in November 2023 and is currently undergoing further training to become a nutritional physician (DGEM).
He is the national representative for the Grand Duchy of Luxembourg at the ESMO (European Society for Oncology) and has a seat on the Board of Directors of the INC (Institut national du cancer), where he represents the CHdN (Centre Hospitäler du Nord).
